$LAGBF Shares Rise After Cannabidiol Clinical Tria
Post# of 102204
Posted On: 07/19/2016 10:00:02 AM
$LAGBF Shares Rise After Cannabidiol Clinical Trials
Cannabidiol, or CBD, is one of the active cannabinoids present in cannabis, as well as in hemp, a variety of cannabis. Although many people focus on THC, the key psychoactive component in cannabis, CBD, offering medical benefits without psychoactive properties, is becoming increasingly popular. Since a report by the British Journal of Clinical Pharmacology (http://dtn.fm/xX8mG) was published in 2013 suggesting positive CBD applications, including reducing nausea and vomiting, suppressing seizure activity, combatting psychosis, combating tumor and cancer cells, and helping with anxiety and depression, CBD has made significant progress in the world of medicine.
Today, numerous trials are taking place around the world to understand the positive effects of cannabis and its components. Laguna Blends (OTC: LAGBF), a network marketing company based in the U.S. and Canada, focuses on the nutritional benefits of hemp and hemp based products. After the launch of its two products, Caffe and Pro369, the company took its passion for hemp a step further. Shares in Laguna Blends, Inc. shot through the roof as it announced the results of Cannaceuticals’ clinical trials of a cannabis extract facial serum, which showed 100% improvement of the skin of each subject.
The serum was tested on 21 women. Every single woman involved in the clinical trials witnessed an overall improvement in the appearance of their skin. With this, Laguna shares rose by 12.5% to $0.27. With these developments, Laguna Blends could become a player in the skincare industry as well as the functional beverage industry.
By the end of 2016, the skincare market is expected to grow to $121 billion. This growth is expected to reach a huge $154 billion by the end of 2021, according to Statista (http://dtn.fm/V70hE). With Laguna entering into a non-binding letter of intent with Swiss-developed care line Cannaceuticals, the group could incorporate itself within the skincare and beauty industry, as well as the direct sales industry. Ray Grimm Jr., president of Laguna Blends, had this to say in a recent news release: “Management believes that this proposed acquisition will immediately establish Laguna as a player in the skincare category”.
For more information, visit www.lagunablends.com
$LAGBF #hemp #products #coffee #caffee #cafe #protein
Cannabidiol, or CBD, is one of the active cannabinoids present in cannabis, as well as in hemp, a variety of cannabis. Although many people focus on THC, the key psychoactive component in cannabis, CBD, offering medical benefits without psychoactive properties, is becoming increasingly popular. Since a report by the British Journal of Clinical Pharmacology (http://dtn.fm/xX8mG) was published in 2013 suggesting positive CBD applications, including reducing nausea and vomiting, suppressing seizure activity, combatting psychosis, combating tumor and cancer cells, and helping with anxiety and depression, CBD has made significant progress in the world of medicine.
Today, numerous trials are taking place around the world to understand the positive effects of cannabis and its components. Laguna Blends (OTC: LAGBF), a network marketing company based in the U.S. and Canada, focuses on the nutritional benefits of hemp and hemp based products. After the launch of its two products, Caffe and Pro369, the company took its passion for hemp a step further. Shares in Laguna Blends, Inc. shot through the roof as it announced the results of Cannaceuticals’ clinical trials of a cannabis extract facial serum, which showed 100% improvement of the skin of each subject.
The serum was tested on 21 women. Every single woman involved in the clinical trials witnessed an overall improvement in the appearance of their skin. With this, Laguna shares rose by 12.5% to $0.27. With these developments, Laguna Blends could become a player in the skincare industry as well as the functional beverage industry.
By the end of 2016, the skincare market is expected to grow to $121 billion. This growth is expected to reach a huge $154 billion by the end of 2021, according to Statista (http://dtn.fm/V70hE). With Laguna entering into a non-binding letter of intent with Swiss-developed care line Cannaceuticals, the group could incorporate itself within the skincare and beauty industry, as well as the direct sales industry. Ray Grimm Jr., president of Laguna Blends, had this to say in a recent news release: “Management believes that this proposed acquisition will immediately establish Laguna as a player in the skincare category”.
For more information, visit www.lagunablends.com
$LAGBF #hemp #products #coffee #caffee #cafe #protein
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼